Prospects for active and passive immunization against Staphylococcus aureus.
Shinefield
Henry R
HR
University of California, San Francisco, CA, USA.
Black
Steven
S
D000328:Adult; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001426:Bacterial Proteins / Q000235:genetics / Q000276:immunology; D006801:Humans; D007114:Immunization / Q000379:methods*; D007116:Immunization, Passive / Q000379:methods*; D051379:Mice; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013209:Staphylococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology; D013211:Staphylococcus aureus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D037521:Virulence Factors / Q000235:genetics / Q000276:immunology
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D013209:Staphylococcal Vaccines; D037521:Virulence Factors